Ameritas Investment Partners’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-695
| Closed | -$1.41K | – | 3200 |
|
|
2025
Q1 | $1.41K | Hold |
695
| – | – | ﹤0.01% | 3090 |
|
|
2024
Q4 | $4.18K | Hold |
695
| – | – | ﹤0.01% | 3050 |
|
|
2024
Q3 | $4.87K | Hold |
695
| – | – | ﹤0.01% | 3040 |
|
|
2024
Q2 | $4.03K | Hold |
695
| – | – | ﹤0.01% | 3052 |
|
|
2024
Q1 | $4.97K | Hold |
695
| – | – | ﹤0.01% | 2950 |
|
|
2023
Q4 | $3.42K | Hold |
695
| – | – | ﹤0.01% | 3021 |
|
|
2023
Q3 | $6.64K | Hold |
695
| – | – | ﹤0.01% | 2936 |
|
|
2023
Q2 | $9.01K | Hold |
695
| – | – | ﹤0.01% | 2940 |
|
|
2023
Q1 | $8.82K | Buy |
+695
| New | +$8.82K | ﹤0.01% | 2761 |
|